Middle Meningeal Artery Embolization Minimizes Burdensome Recurrence Rates After Newly Diagnosed Chronic Subdural Hematoma Evacuatio

Not Applicable

Recruiting

Conditions: I62.02

Registration Number: DRKS00020465

Lead Sponsor: Klinik für Neurochirurgie BG Klinikum Unfallkrankenhaus Berlin gGmbH

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 154

Inclusion Criteria

1.Patients who were operated on by one or more burr hole trepanations for a first manifestation of a cSDH (unihemispheric or bihemispherical) proven in computer tomography or magnetic resonance tomography
2. Age =18 years
3. Adequate compliance and capacity to consent
4. Declaration of consent for the operation and study participation by the patient

Exclusion Criteria

1. Conservatively treated cSDH
2. Radiological detection of an acute or subacute subdural hematoma, subarachnoid hemorrhage, intracerebral hematoma, epidural hematoma
3. Surgical technique: craniotomy, craniectomy, bilateral burr hole trepanation
4. Angiography cannot be performed within 72 hours after surgery
5. Age <18 years
6. Supervisory relationship
7. Pregnancy
8. No declaration of consent
9. Lack of compliance
10. Homozygous factor XIII deficiency with RA <10%

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence of cSDH after operative therapy within 3 months after inclusion.

Secondary Outcome Measures

Name	Time	Method
1. Impairment through neurological deficits assessed by the modified Rankin scale (mRS) 3 months after inclusion<br>2. Number of recurrence-associated complications with within 3 months of inclusion<br>3. 2. Number of complications associated with interventional therapy within 3 months of inclusion